Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M. D. Evsikova"'
Publikováno v:
Oftalʹmologiâ, Vol 19, Iss 2, Pp 452-457 (2022)
The World Health Organization announced a new coronavirus pandemic on 11 March 2020. It is known that the most frequent clinical manifestation of a new coronavirus infection is lung damage with the evolution of pneumonia, as well as respiratory distr
Externí odkaz:
https://doaj.org/article/aad827a74340446bbd83afa4e0faa9cd
Publikováno v:
Научно-практическая ревматология, Vol 59, Iss 3, Pp 357-361 (2021)
The present report illustrates efficacy of rituximab (RTX) in granulomatosis with polyangiitis (GPA) with severe lung involvement. Female patient, 45 years old, was ill since March 2016, her disease manifested at the onset with fever, recurrent epist
Externí odkaz:
https://doaj.org/article/98cb1688b2374ae7aa9640429be198b0
Publikováno v:
Современная ревматология, Vol 9, Iss 1, Pp 66-71 (2015)
Muckle-Wells syndrome (MWS) is an autoinflammatory disease belonging to a group of cryopyrin-associated periodic syndromes (CAPS). It is considered to be one of the intermediately severe conditions among CAPSs and to be intermediate between the sever
Externí odkaz:
https://doaj.org/article/58f30c20ba654c7d8c5d1b04e0fadea3
Publikováno v:
Терапевтический архив, Vol 89, Iss 11, Pp 111-115 (2017)
The paper reviews the publications dealing with Schnitzler syndrome, a rare autoinflammatory disease, and describes the authors’ own clinical observation. It describes the first Russian experience in successfully using the interleukin-1 inhibitor c
Externí odkaz:
https://doaj.org/article/66dcfa80b8d64868983212ce563efaa5
Publikováno v:
Терапевтический архив, Vol 89, Iss 11, Pp 111-115 (2017)
The paper reviews the publications dealing with Schnitzler syndrome, a rare autoinflammatory disease, and describes the authors' own clinical observation. It describes the first Russian experience in successfully using the interleukin-1 inhibitor can
Autor:
M D, Evsikova, Iu V, Muraviev
Publikováno v:
Terapevticheskii arkhiv. 77(5)
To specify causes of discontinuation of the disease-modifying antirheumatic drugs (DMAD) used in rheumatoid arthritis (RA) by the results of special questionnaire survey.The study included 298 RA patients treated in the Institute of Rheumatology (34
Autor:
Y. V. Muravyov, M D Evsikova
Publikováno v:
Научно-практическая ревматология, Vol 42, Iss 3, Pp 89-90 (2004)
Autor:
M D Evsikova, Y. V. Muravyov
Publikováno v:
Научно-практическая ревматология, Vol 42, Iss 3, Pp 89-90 (2004)
Externí odkaz:
https://doaj.org/article/20a585874c284d768887c8546402f789
Autor:
M D Evsikova, Y V Muravyov
Publikováno v:
Научно-практическая ревматология, Vol 42, Iss 1, Pp 82-83 (2004)
Externí odkaz:
https://doaj.org/article/9786e7bcb4e643c4afc44bdb00ab7c94